News | Cardiovascular Business | August 02, 2023

Dr. Doria A. Scortichini MD, FACC Joins Auburn Heart Institute

Dr. Scortichini is recognized across the Finger Lakes and Greater Rochester region as one of the most respected and accomplished cardiologists 

Dr. Scortichini is recognized across the Finger Lakes and Greater Rochester region as one of the most respected and accomplished cardiologists

Doria Scortichini, MD FACC 


August 2, 2023 —   Dr. Doria Scortichini, MD FACC joins the growing Auburn Heart Institute that is affiliated with Auburn Community Hospital.  Dr. Scortichini is a cardiology specialist in Geneva, New York and has over 40 years of experience in cardiovascular diseases.  Dr. Scortichini graduated from Albany Medical College of Union University and completed her residency and cardiology fellowship at Bronx Municipal Hospital and Albert Einstein College of Medicine Hospital followed by a fellowship in interventional cardiology at the Montreal Heart Institute. Dr. Scortichini is board certified in Internal Medicine and Cardiovascular Diseases. 

Dr. Scortichini will continue to provide the same high level cardiac care as part of the Auburn Heart Institute located not far from her current practice. Dr. Scortichini is accepting new patients and we invite current patients to take the short drive to Auburn in order to continue to receive the outstanding care you have come to rely upon from Dr. Scortichini. Patients can begin scheduling appointments immediately by calling the number below. 

"We are thrilled to have someone of Dr. Scortichini' s experience join the Auburn Heart Institute and Auburn Community Hospital. Dr. Scortichini is recognized by her patients and colleagues throughout the Finger Lakes region as a very respected heart specialist who has been diagnosing, preventing, and treating heart disease in our region for years and will be a tremendous asset as we build the Auburn Heart Institute, and care for patients throughout the Finger Lakes region," stated Dr. Ronald Kirshner, Chair & Medical Director of the Auburn Heart Institute. 

"I am excited to join the team at the Auburn Heart Institute, and to be part of Auburn Hospital and this community.  Dr. Kirshner and Scott Berlucchi are building a first-class comprehensive cardiology center, and I look forward to being part of this patient centered endeavor.  The Heart Institute is committed to bringing in a very talented multidisciplinary team.  These physicians are currently treating patients as we simultaneously begin building the new Heart Institute.  I am impressed with the investments Auburn Community Hospital's leadership has made in new technology and talent to care for all the patients in our region," stated Dr. Scortichini.   

For more information: https://www.auburnhospital.org/ 


Related Content

News | Heart Failure

May 22, 2024 — New research from The Cooper Institute and partners at University of Texas (UT) Southwestern Medical ...

Home May 22, 2024
Home
News | Heart Failure

April 30, 2024 — A multicenter study led by Vanderbilt University Medical Center (VUMC) and Lipscomb University College ...

Home April 30, 2024
Home
News | Heart Failure

April 16, 2024 — Each year more than 500,000 Americans undergo percutaneous coronary intervention, or PCI, a minimally ...

Home April 16, 2024
Home
News | Heart Failure

April 12, 2024 — University of Virginia School of Medicine researchers have discovered a gene on the Y chromosome that ...

Home April 12, 2024
Home
News | Heart Failure

April 2, 2024 — People who use e-cigarettes are significantly more likely to develop heart failure compared with those ...

Home April 02, 2024
Home
News | Heart Failure

March 29, 2024 — V-Wave announced it will present late-breaking data from its RELIEVE-HF pivotal trial at the American ...

Home March 29, 2024
Home
News | Heart Failure

March 25, 2024 — A team of engineers led by the University of Massachusetts Amherst and including colleagues from the ...

Home March 25, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc. , a biotechnology company focused on advancing late-stage cell therapy interventions ...

Home March 15, 2024
Home
News | Heart Failure

March 15, 2024 — BioCardia, Inc., a biotechnology company focused on advancing late-stage cell therapy interventions for ...

Home March 15, 2024
Home
News | Heart Failure

March 13, 2024 — BioCardia, Inc., a developer of cellular and cell-derived therapeutics for the treatment of ...

Home March 13, 2024
Home
Subscribe Now